A study by Harbinski et al. [93] used a cDNA library encoding secreted proteins to systematically assess the potential of secreted proteins including diverse growth factors to induce resistance to kinase inhibitors in cancer cell lines highly addicted to MET, FGFR2 or FGFR3. This evidence concerns the gene MET and cancer.